202 related articles for article (PubMed ID: 30227236)
1. Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer's disease and protection effects of zinc and fluvastatin.
Yao D; Jing T; Niu L; Huang X; Wang Y; Deng X; Wang M
Brain Res Bull; 2018 Oct; 143():1-8. PubMed ID: 30227236
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain.
Larry Sparks D
J Mol Neurosci; 2004; 24(1):97-104. PubMed ID: 15314257
[TBL] [Abstract][Full Text] [Related]
3. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease.
Sparks DL; Schreurs BG
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11065-9. PubMed ID: 12920183
[TBL] [Abstract][Full Text] [Related]
4. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of amyloidogenesis and memory impairment by estrogen deficiency through NF-κB dependent beta-secretase activation in presenilin 2 mutant mice.
Hwang CJ; Park MH; Choi MK; Choi JS; Oh KW; Hwang DY; Han SB; Hong JT
Brain Behav Immun; 2016 Mar; 53():113-122. PubMed ID: 26593275
[TBL] [Abstract][Full Text] [Related]
6. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
7. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
[TBL] [Abstract][Full Text] [Related]
8. Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery.
Vilella A; Belletti D; Sauer AK; Hagmeyer S; Sarowar T; Masoni M; Stasiak N; Mulvihill JJE; Ruozi B; Forni F; Vandelli MA; Tosi G; Zoli M; Grabrucker AM
J Trace Elem Med Biol; 2018 Sep; 49():210-221. PubMed ID: 29325805
[TBL] [Abstract][Full Text] [Related]
9. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
11. The link between altered cholesterol metabolism and Alzheimer's disease.
Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
[TBL] [Abstract][Full Text] [Related]
12. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease.
Atamna H
J Alzheimers Dis; 2006 Nov; 10(2-3):255-66. PubMed ID: 17119291
[TBL] [Abstract][Full Text] [Related]
13. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.
Peters DG; Pollack AN; Cheng KC; Sun D; Saido T; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
Metallomics; 2018 Mar; 10(3):426-443. PubMed ID: 29424844
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice.
Park IH; Hwang EM; Hong HS; Boo JH; Oh SS; Lee J; Jung MW; Bang OY; Kim SU; Mook-Jung I
Neurobiol Aging; 2003 Sep; 24(5):637-43. PubMed ID: 12885571
[TBL] [Abstract][Full Text] [Related]
15. Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid beta (Abeta) in rabbit brain.
Sparks DL; Lochhead J; Horstman D; Wagoner T; Martin T
J Alzheimers Dis; 2002 Dec; 4(6):523-9. PubMed ID: 12515903
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
Cherny RA; Atwood CS; Xilinas ME; Gray DN; Jones WD; McLean CA; Barnham KJ; Volitakis I; Fraser FW; Kim Y; Huang X; Goldstein LE; Moir RD; Lim JT; Beyreuther K; Zheng H; Tanzi RE; Masters CL; Bush AI
Neuron; 2001 Jun; 30(3):665-76. PubMed ID: 11430801
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
18. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
19. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
Murakami K; Murata N; Noda Y; Tahara S; Kaneko T; Kinoshita N; Hatsuta H; Murayama S; Barnham KJ; Irie K; Shirasawa T; Shimizu T
J Biol Chem; 2011 Dec; 286(52):44557-68. PubMed ID: 22072713
[TBL] [Abstract][Full Text] [Related]
20. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
